Atara Biotherapeutics, Inc. (ATRA)
Nasdaq: ATRA · Biological Products, (No Diagnostic Substances) · Thousand Oaks, CA · filing with the SEC since 2014
The company now
Atara Biotherapeutics, Inc. is classed by the SEC under Biological Products, (No Diagnostic Substances) (industry code 2836), based in Thousand Oaks, CA. In its latest annual figures on file, for the fiscal year ended 2025-12-31, it reported revenue of $121 million and a profit of $33 million (its filed statements).
From its filings and filed figures; the desk's account of it is not written yet.
The desk's written account, its read of the annual report, the record in brief and the split of the revenue are not on file for this company yet.